Shares of Bristol-Myers Squibb Co (NYSE:BMY) ended Monday session in green amid volatile trading. The shares closed up +0.65 points or 1.17% at $56.32 with 9.96 million shares getting traded. Post opening the session at $55.30, the shares hit an intraday low of $55.02 and an intraday high of $56.44 and the price vacillated in this range throughout the day. The company has a market cap of $92.20 billion and the numbers of outstanding shares have been calculated to be 1.66 billion shares.
Bristol-Myers Squibb Co (BMY) announced that it will take part in the Morgan Stanley 2016 Global Health Care Conference on Tuesday, September 13, 2016, in New York. Giovanni Caforio, M.D., chief executive officer will make formal remarks about the company and answer questions at 11:10 a.m. EDT.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.
Shares of CVS Health Corp (NYSE:CVS) ended Monday session in green amid volatile trading. The shares closed up +0.49 points or 0.54% at $92.04 with 5.24 million shares getting traded. Post opening the session at $91.40, the shares hit an intraday low of $91.04 and an intraday high of $92.26 and the price vacillated in this range throughout the day. The company has a market cap of $96.46 billion and the numbers of outstanding shares have been calculated to be 1.07 billion shares.
CVS Health Corp (CVS) on Sept. 12, 2016 announced that it has partnered with the YMCA of the USA (Y-USA) to help expand two programs that provide critical support to people across the country: the Diabetes Prevention Program and the nationally recognized LIVESTRONG® Foundation at the YMCA program.
“At CVS Health, we’re focused on providing resources and services that empower patients to manage their health in more affordable and effective ways,” said Eileen Howard Boone, senior vice president of Corporate Social Responsibility and Philanthropy at CVS Health. “We’re proud to partner with Y-USA to help both cancer survivors and those at risk of diabetes on their path to better health – whether it’s helping them learn healthy eating habits or improving their physical and emotional well-being.”
The YMCA’s Diabetes Prevention Program is a group-based lifestyle intervention for adults at high risk of developing type 2 diabetes. Through a 12-month evidence-based plan, the program has been successful in reducing the number of new cases of diabetes by 58 percent overall and by 71 percent in adults over 60.
LIVESTRONG at the YMCA is a 12-week evidence-based program that focuses on best practices for physical activity and well-being initiatives for cancer survivors. The program empowers adult cancer survivors to improve functional capacity and to increase their quality of life through an organized program of fitness and strength offered in a supportive, small-group setting.
“As a leading community-based organization committed to improving America’s health, our goal is to provide everyone access to initiatives like the YMCA’s Diabetes Prevention Program and the LIVESTRONG at the YMCA program,” said Dr. Matt Longjohn, National Health Officer, Y-USA. “Through the generosity of CVS Health, local YMCAs will be able to provide free access to services for diabetes patients and cancer survivors, who may not otherwise be able to participate in these valuable support programs.”